CETIN, T. Et Al. 1994. ETIOLOGY OF SERUM CA-125 IN PATIENTS WITH ENDOMETRIOSIS TREATED WITH A GONADOTROPIN-RELEASING-HORMONE AGONIST (BUSERELIN). GYNECOLOGIC AND OBSTETRIC INVESTIGATION , vol.38, no.4 , 249-252.

CETIN, T., VARDAR, M., DEMIR, C., & BURGUT, R., (1994). ETIOLOGY OF SERUM CA-125 IN PATIENTS WITH ENDOMETRIOSIS TREATED WITH A GONADOTROPIN-RELEASING-HORMONE AGONIST (BUSERELIN). GYNECOLOGIC AND OBSTETRIC INVESTIGATION , vol.38, no.4, 249-252.

CETIN, T Et Al. "ETIOLOGY OF SERUM CA-125 IN PATIENTS WITH ENDOMETRIOSIS TREATED WITH A GONADOTROPIN-RELEASING-HORMONE AGONIST (BUSERELIN)," GYNECOLOGIC AND OBSTETRIC INVESTIGATION , vol.38, no.4, 249-252, 1994

CETIN, T Et Al. "ETIOLOGY OF SERUM CA-125 IN PATIENTS WITH ENDOMETRIOSIS TREATED WITH A GONADOTROPIN-RELEASING-HORMONE AGONIST (BUSERELIN)." GYNECOLOGIC AND OBSTETRIC INVESTIGATION , vol.38, no.4, pp.249-252, 1994

CETIN, T. Et Al. (1994) . "ETIOLOGY OF SERUM CA-125 IN PATIENTS WITH ENDOMETRIOSIS TREATED WITH A GONADOTROPIN-RELEASING-HORMONE AGONIST (BUSERELIN)." GYNECOLOGIC AND OBSTETRIC INVESTIGATION , vol.38, no.4, pp.249-252.

@article{article, author={T CETIN Et Al. }, title={ETIOLOGY OF SERUM CA-125 IN PATIENTS WITH ENDOMETRIOSIS TREATED WITH A GONADOTROPIN-RELEASING-HORMONE AGONIST (BUSERELIN)}, journal={GYNECOLOGIC AND OBSTETRIC INVESTIGATION}, year=1994, pages={249-252} }